Omega Healthcare Investors Inc (NYSE:OHI) – Research analysts at SunTrust Banks cut their Q1 2018 earnings estimates for shares of Omega Healthcare Investors in a note issued to investors on Wednesday, according to Zacks Investment Research. SunTrust Banks analyst E. Fleming now forecasts that the real estate investment trust will post earnings of $0.72 per share for the quarter, down from their prior estimate of $0.79. SunTrust Banks has a “Hold” rating and a $26.00 price objective on the stock. SunTrust Banks also issued estimates for Omega Healthcare Investors’ Q2 2018 earnings at $0.71 EPS, Q3 2018 earnings at $0.73 EPS, Q4 2018 earnings at $0.75 EPS, Q1 2019 earnings at $0.77 EPS, Q2 2019 earnings at $0.78 EPS, Q3 2019 earnings at $0.78 EPS and Q4 2019 earnings at $0.79 EPS.
OHI has been the subject of a number of other reports. ValuEngine upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Friday, December 15th. Cantor Fitzgerald reiterated a “buy” rating and set a $34.00 price target on shares of Omega Healthcare Investors in a report on Tuesday, February 13th. Zacks Investment Research cut Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Tuesday, February 20th. Wells Fargo & Co upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $32.00 target price for the company in a report on Thursday, February 15th. Finally, Jefferies Group restated an “underperform” rating on shares of Omega Healthcare Investors in a report on Thursday, December 21st. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the stock. Omega Healthcare Investors currently has an average rating of “Hold” and a consensus price target of $31.37.
Omega Healthcare Investors (NYSE OHI) traded up $0.02 during midday trading on Monday, hitting $27.32. The stock had a trading volume of 1,409,783 shares, compared to its average volume of 2,850,000. The stock has a market cap of $5,430.00, a PE ratio of 59.39, a PEG ratio of 3.12 and a beta of 0.46. The company has a current ratio of 3.55, a quick ratio of 3.55 and a debt-to-equity ratio of 1.18. Omega Healthcare Investors has a fifty-two week low of $24.90 and a fifty-two week high of $35.14.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, February 13th. The real estate investment trust reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.18). The business had revenue of $221.21 million for the quarter, compared to analysts’ expectations of $219.07 million. Omega Healthcare Investors had a return on equity of 2.48% and a net margin of 11.06%.
A number of institutional investors have recently made changes to their positions in the stock. Barnett & Company Inc. boosted its stake in shares of Omega Healthcare Investors by 1,980.0% in the 3rd quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock valued at $166,000 after buying an additional 4,950 shares during the period. Mcmillion Capital Management Inc. purchased a new position in shares of Omega Healthcare Investors in the 3rd quarter valued at about $201,000. Lourd Capital LLC purchased a new position in shares of Omega Healthcare Investors in the 4th quarter valued at about $202,000. Timber Hill LLC purchased a new position in shares of Omega Healthcare Investors in the 3rd quarter valued at about $206,000. Finally, Good Life Advisors LLC purchased a new position in shares of Omega Healthcare Investors in the 3rd quarter valued at about $209,000. Institutional investors own 73.86% of the company’s stock.
In other news, Director Bernard J. Korman bought 100,000 shares of the stock in a transaction that occurred on Friday, December 22nd. The stock was bought at an average cost of $26.89 per share, for a total transaction of $2,689,000.00. Following the acquisition, the director now directly owns 896,895 shares of the company’s stock, valued at approximately $24,117,506.55. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.54% of the company’s stock.
The company also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Wednesday, January 31st were issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 9.66%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.65. The ex-dividend date of this dividend was Tuesday, January 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 573.91%.
TRADEMARK VIOLATION WARNING: This report was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thelincolnianonline.com/2018/03/14/q1-2018-eps-estimates-for-omega-healthcare-investors-inc-ohi-cut-by-analyst.html.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.